Public recall detail

Pregnancy Multivitamin, Pregnancy Multivitamin Folic 5: Affected lots exceed the acceptable intake limit for N-nitroso-folic acid

2024-10-16

medium
Recall Safety notice
Quick summary

Quick summary: Pregnancy Multivitamin, Pregnancy Multivitamin Folic 5: Affected lots exceed the acceptable intake limit for N-nitroso-folic acid. Date: 2024-10-16.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Pregnancy Multivitamin, Pregnancy Multivitamin Folic 5: Affected lots exceed the acceptable intake limit for N-nitroso-folic acid. Date: 2024-10-16.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

BrandJAMP, JAMP Pharma
ProductPregnancy Multivitamin, Pregnancy Multivitamin Folic 5
IssueHealth products - Product safety
Recall classType II
IdentificationRA-76338

Affected products

BrandJAMP Pharma
ProductPregnancy Multivitamin
DIN / NPN / authorizationDIN 02535718
Dosage formTablet
StrengthBlue tablets only: Folic acid 1.1 mg / Vitamin B12 12 mcg / Vitamin D3 600 IU / Calcium 300 mg
LotLKE08 Additional Lots: LKE05, LKE07, LKE09
BrandJAMP Pharma
ProductPregnancy Multivitamin Folic 5
DIN / NPN / authorizationDIN 02537478
Dosage formTablet
StrengthDark Blue tablets only: Folic acid 5 mg / Vitamin B12 12 mcg / Vitamin D3 600 IU / Calcium 300 mg
LotLKE10, LKE11, LKE14

Issue

Affected lots exceed the acceptable intake limit for N-nitroso-folic acid

What you should do

  • Verify if your product is affected.
  • Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  • Contact the recalling firm if you have any questions about the recall.
  • Report any health product related side effects to Health Canada.
  • Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Children, pregnant or breast feeding women Healthcare Industry
CategoryHealth products - Drugs
CompaniesJAMP Pharma Corporation. 1310 Nobel, Boucherville, QC, J4B 5H3
DistributionNational Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Ontario Quebec Saskatchewan
Published byHealth Canada
Recall classType II
Alert / recall typeHealth product recall
Identification numberRA-76338
Background{}
CompaniesJAMP Pharma Corporation. 1310 Nobel, Boucherville, QC, J4B 5H3
AudiencesGeneral public Children, pregnant or breast feeding women Healthcare Industry
Source updated2024-11-06

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...